The Importance of Breathomics
In summary, Breathomics is the study of Volatile Organic Compounds (VOCs) in the human breath. Analysis of human breath can be used in clinical research to identify or explain physiological mechanisms or to diagnose respiratory conditions. Exhaled breath samples or condensate samples are analysed using gas chromatography and mass spectrometry. These methods quantify VOCs in […]
Breath Analysis and VOCs for Infectious Disease Screening
In recent months, breath analysis has been receiving a high amount of attention in the healthcareworld because it provides a non-invasive clinical test with results being used for early diseasedetection. What is Breath Analysis? Your breath can highlight a lot of information if you know what to look for. Besides giving away thatyou may have […]
Imspex Diagnostics to Partner with Bond Digital Health
Imspex Diagnostics Ltd is delighted to have entered into a technology development and commercialisation partnership project with Bond Digital Health. Both businesses are Wales-based specialists in Life Sciences that will combine Imspex’s ‘early warning systems’ for healthcare using its market-leading gas chromatography (GC) and Ion Mobility Spectrometry (IMS) technology combined with Bond’s world’s first Transform® […]
BreathSpec’s Proven Accuracy on Breath Analysis
Healthcare providers globally are increasingly looking towards Breath Analysis as a potential new, non-invasive way of screening for and diagnosing health conditions. In current circumstances where respiratory conditions are prevalent, this need cannot be over-emphasised. Imspex’s BreathSpec® uses gas chromatography coupled with ion-mobility spectrometry (GC-IMS), combining the high discernment of chromatographic separation with highly specific […]
Talking about breath analysis on Radio Intereconomía
Santi Dominguez, Imspex’s CEO, spoke with Radio Intereconomía’s Gema González on the Visíon Global programme on 28 July 2021. Listen to their conversation about breath analysis as a rapid and non-invasive detection technology that is ideal for use at point-of-care with diseases including respiratory tract infections, COVID-19, lung cancer and Alzheimer’s disease. More details from […]
Pipeline Corner for Diagnostics at ECCMID 2021
It was a pleasure to be part of the speaker line-up at ECCMID 2021’s Pipeline Corner for Diagnostics on Saturday 10 July, along with speakers from Novel Microdevices, Fraunhofer UK Research, FluoretiQ Limited, Module and BioAmp Diagnostics. This session was a fantastic opportunity to showcase breath analysis as an emerging strategy for detection and early […]
Breath analysis as a rapid diagnostic for respiratory tract infections
Patients with respiratory tract infections form a large part of general practitioners’ caseloads. In the absence of quick, convenient, accurate, and acceptable ways of identifying the agents causing these infections, GPs often find themselves at the centre of competing patient expectations, antimicrobial stewardship requirements and economic imperatives when prescribing interventions for these infections. This is […]
BreathSpec® features at ADTCA 2021
#ADTCA2021 saw more than 75 delegates from 23 countries gather online on 24 June 2021 to discuss how data tech can be used to prevent, detect and diagnose infectious disease, enable antimicrobial stewardship and underpin effective antimicrobial therapeutics. We were delighted to be able to join this meeting and to share some of our experiences […]
Hepatocellular carcinoma urinary biomarker detection using GC-IMS
A team of clinical and engineering researchers from the University of Warwick, Coventry University and the University of Leicester recently confirmed the feasibility of identifying urinary hepatocellular carcinoma (HCC) biomarkers using the Imspex Group’s proprietary gas chromatography-ion mobility spectrometry (GC-IMS) technology. In a pilot study, volatile organic compound (VOC) peaks representative of HCC were identified […]
Taking breath analysis into the future
Human breath contains up to a thousand volatile organic compounds that, when analysed, can tell a story about a body’s state of health. These chemical compounds reflect the end processes of metabolic pathways. Patterns of compound peaks form ‘signatures’ when breath is analysed into its components and it is these signatures that allow for disease […]
A patent for our technology
Congratulations @Imspex_GAS on the granting of your patent for measurement of human breath using gas chromatography and ion mobility spectrometry. This is the foundation for the robust GC-IMS technology in BreathSpec® and FluidSpec® that has proven capability to screen for disease indications such as bacterial and viral respiratory tract infections, Group B Streptococcus infection, lung […]
Breath analysis for COVID-19 screening
A rapid and non-invasive test that can identify whether COVID-19 is present or not can make all the difference in giving people peace of mind to attend appointments for existing medical conditions or to get going again with business, education and sporting activities. This is one of the driving factors for the work of Dr […]